home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  November 21, 2024
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 460 active entries

Chemleader Biomedical Co., Ltd.

Building 3, No.1666, Xinyang Highway, Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone 201413 P.R. China
201413
China

Phone: +86-21-58180488
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Description:

    Chemleader Biomedical Co., Ltd. was established in 2010 and is a leading global supplier of research chemicals and bioactive reagents. Chemleader Biomedical has over 8000 products from over 20 signaling pathways and 400 targets. The product is constantly being updated. Its range of products exhibit known biological activities that have found uses in a wide array of research fields, especially cancer and neuroscience. These products include protein kinase inhibitors, ion channel modulators, and activators. Chemleader Biomedical offers a wide range of high-quality research chemicals including novel life-science reagents, inhibitors, peptides, activator,antibody, APIs and natural compounds for scientific use.

Our primary focus is distributing high-quality reagents that support research scientists across academic, biotechnology, biomedical, and pharmaceutical institutions. We strive to establish the most comprehensive global inventory of small molecule research drugs and are committed to deliver superior reagents at competitive prices. Chemleader Biomedical is viewed as a strategic partner to many of the leading companies in the market. Below are some of our strong products:
 

Trastuzumab (anti-HER2)CAS:180288-69-1

Y-27632 Dihydrochloride CAS:129830-38-2

RepSox(ALK5 Inhibitor II) CAS:446859-33-2

Ranibizumab (Anti-VEGFA) CAS:347396-82-1

Nintedanib Ethanesulfonate Salt CAS:656247-18-6

Dydrogesterone CAS:152-62-5

Cycloastragenol CAS:78574-94-4

Genipin CAS:6902-77-8

We value the relationships with our partners and customers and are driven to exceed current limitations with flexibility, innovation and highly customized solutions to match specific requirements.
 



Selected Categories:
Product Company   Service Company
Biopharma
- Research
Biotech
- Research
Pharmaceutical
- Research
Supplier
- Laboratory
- Medical
- Research
Contract
- Production

Last update of this entry: September 09, 2024

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.